Aug 4 (Reuters) – The U.S. Federal Trade Commission is taking a closer look at a proposed $3.5 billion acquisition that would combine two of the leading national suppliers of veterinary products, Cencora’s MWI Animal Health and privately held Covetrus, Bloomberg News reported on Tuesday. The antitru
Israeli Agricultural Expertise Helps Cultivate Tanzania’s Growing Wine Industry Tanzania is East Africa’s only commercial wine producer and has favorable conditions for expanding grape cultivation By Keren Setton / The Media Line On the rolling hills outside Dodoma, Tanzania’s wine capital, an agric
By David Shepardson WASHINGTON, Aug 4 (Reuters) – The Federal Aviation Administration on Tuesday proposed giving airlines flexibility in requirements for emergency medical kits on commercial flights. The FAA is proposing moving from a prescriptive checklist of medical items and instead setting perfo
Aug 4 (Reuters) – Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus, a strain of Ebola that has killed more than 1,650 people so far and currently has no approved vaccine. Health Canada has cleared an early-stage study and
By Siddhi Mahatole Aug 4 (Reuters) – Medical equipment maker Revvity raised its annual profit and revenue forecasts on Tuesday, after topping Wall Street estimates for the second quarter helped by improving demand for its drug-development tools and diagnostic testing products. “It appears that our p
CAIRO (AP) — A reported strike in the Strait of Hormuz, fresh claims about U.S.-Iran talks, renewed diplomatic mediation efforts, and continued flashpoints in Yemen and Gaza were among the major developments unfolding Tuesday across the region. Cargo ship hit in Strait of Hormuz heightens shipping f
Aug 4 (Reuters) – Rhythm Pharmaceuticals said on Tuesday its experimental weekly injectable drug helped reduce body weight in patients with a rare form of obesity caused by damage to the brain, according to preliminary data from an ongoing mid-stage study. Shares of the Boston-based company were up
By Michael Erman and Christy Santhosh Aug 4 (Reuters) – Merck reported higher-than-expected second-quarter sales on Tuesday and raised its full-year revenue forecast on the strength of its top-selling cancer treatment Keytruda. The U.S. drugmaker reported quarterly revenue of $16.61 billion, up 5% f
Aug 4 (Reuters) – Biopharmaceutical company Attovia Therapeutics said on Tuesday it was targeting a valuation of $731.5 million in its upsized initial public offering, signaling strong demand for biopharma listings. Here are some details: • The San Carlos, California-based company is now seeking $28
By Neil J Kanatt and Alexander Marrow Aug 4 (Reuters) – Kimberly-Clark cut annual sales and profit forecasts on Tuesday and said false claims about its diaper quality in China will continue to be a problem after hurting second-quarter sales. The Kleenex maker, whose shares were volatile in early tra
BERLIN, Aug 4 (Reuters) – German vaccine maker BioNTech significantly lowered its full year sales outlook range on Tuesday due to softer-than-expected COVID-19 vaccine demand, as second quarter revenue fell by more than half and its net loss more than doubled. Shares were down 5.5% at 1106 GMT follo
By Olivia Le Poidevin GENEVA, Aug 4 (Reuters) – Testing of experimental treatments, preventive medicines and vaccines for the Bundibugyo strain of Ebola behind Democratic Republic of Congo’s ongoing outbreak is advancing rapidly, the U.N.’s World Health Organization said on Tuesday. The epidemic – t
Aug 4 (Reuters) – India’s Alembic Pharmaceuticals on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for generic drugs in its key U.S. market. • Consolidated profit after non-controlling interests rose to 1.73 billion rupees ($18.14 million), from 1.54 billion rupe
August 4 (Reuters) – British medical products maker Convatec on Tuesday forecast its second-half operating margin to be materially higher than the first half, and pointed to accelerating demand for its infusion care products. Here are some more details: • Convatec said growth would accelerate in the
Aug 4 (Reuters) – Fresenius Medical Care shares fell in early trade on Tuesday, as investors looked past a second-quarter profit beat to focus on a fresh disappointment in U.S. patient volumes and the management’s decision to merely confirm, not raise, the full-year guidance. Shares in the world’s l
By Raechel Thankam Job Aug 4 (Reuters) – Smith+Nephew cut its forecast for annual revenue growth on Tuesday after missing second-quarter expectations, knocking its shares, as the British medical products maker grapples with weak knee implant demand and skin graft prices. After three years of cost cu
By Rishika Sadam NEW DELHI, Aug 4 (Reuters) – India’s pharmaceutical industry is likely to miss its sales target for the end of the decade as U.S. tariff uncertainty and Middle East shipping disruptions weigh on exports, the head of a government-backed trade body told Reuters. The sector is now expe
Aug 4 (Reuters) – New York City-based Pathos AI will pay $125 million upfront to a subsidiary of Alphamab Oncology for rights to an experimental drug for a type of breast cancer, the Chinese oncology specialist said Tuesday, as it competes with bigger rivals. Triple-negative breast cancer, or TNBC,
By Sneha S K and Deena Beasley Aug 3 (Reuters) – Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval. “For a limited number of patients who meet specific medical criteria and cannot enro
By Nancy Lapid Aug 3 (Reuters) – The overall cost of containing a 2025 measles outbreak in New Mexico was nearly $5.4 million, a new study estimates. The figure includes expenses for medical care, public health services and lost productivity, not just for the 57 adult patients and for caregivers of
Aug 3 (Reuters) – Vertex Pharmaceuticals on Monday raised the upper end of its annual revenue forecast, banking on robust demand for its cystic fibrosis treatments. The company expects its annual revenue to be between $13.1 billion and $13.2 billion, compared with $12.95 billion to $13.1 billion pre
By Jonathan Stempel Aug 3 (Reuters) – California’s highest court ruled on Monday that manufacturers of drugs that are considered safe do not owe a duty to patients to try developing drugs that could be even safer, ruling in favor of Gilead Sciences in the closely watched case. In a 6-1 decision, the
DETROIT (AP) — Two people have died in the cyclospora outbreak in Michigan, state health officials announced Monday, the first deaths confirmed in the U.S. related to the microscopic parasite. The Michigan Department of Health and Human Services said both people had underlying health conditions that
Aug 3 (Reuters) – Fresenius Medical Care on Monday reported second-quarter operating income well ahead of market expectations and reaffirmed its full-year outlook, as its cost-cutting programme and favourable U.S. reimbursement rates offset a deepening decline in patient treatment volumes. The world
By Jonathan Stempel Aug 3 (Reuters) – California’s highest court on Monday ruled in favor of Gilead Sciences in a closely watched case addressing whether manufacturers of drugs that are considered safe must try developing drugs that could be safer. In a 6-1 decision, the California Supreme Court ord
By Aditya Kalra NEW DELHI, Aug 3 (Reuters) – India’s food safety regulator has barred the sale of some popular whiskies and rum made by Diageo’s India unit and India’s Inbrew Beverages for using artificial flavouring instead of proper ageing and ingredients to achieve their taste and aroma. India is
Aug 3(Reuters) – Drug developers Latigo Biotherapeutics and BlossomHill Therapeutics launched their U.S. initial public offerings on Monday riding the wave of biotech listings. Biotech IPOs are tapping renewed capital flows, but the rally could stall if continuing Middle East tensions fuel inflation
WASHINGTON (AP) — President Donald Trump’s administration is planning a dramatic overhaul of Head Start that would gut its quality standards, upending the hallmarks of the early education program for impoverished children, two people familiar with the deliberations said. Head Start, established in t
By Kamal Choudhury and Kunal Das Aug 3 (Reuters) – Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 billion, as the private equity-backed firm looks to expand its footprint in the fast-growing sector. Radiopharmaceuticals, which use radioactive com
By Padmanabhan Ananthan Aug 3 (Reuters) – KKR will take medical-device manufacturer Integer Holdings private in an all-cash deal valued at about $5.7 billion, expanding its healthcare portfolio with the acquisition of a key supplier to the medtech industry. Shares of Plano, Texas-based Integer Holdi
